Flightpath Biosciences, Inc.
PrivateLast Round
Series A
Oct 23, 2024
Est. Valuation
$19M
Total Funding Raised
$8.25M
Company Overview
Flightpath Biosciences, Inc. is a biotechnology company that develops precision therapeutics targeting bacterial pathogens to treat infection-associated complex diseases while sparing the microbiome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Flightpath Biosciences, Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Flightpath Biosciences, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 23, 2024 | ||||
| Seed | Mar 8, 2023 | ||||
| Accelerator | Feb 9, 2021 |
Flightpath Biosciences, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Steven & Alexandra Cohen Foundation | Series A |
| Ann Arbor SPARK | Series A |
| Northern Michigan Angels | Series A |
| Michigan Rise | Series A, Seed |
| Michigan Strategic Fund | Seed |
| ID Ventures | Series A |
| Bay Area Lyme Foundation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 23, 2024
$8M round with participation from Steven & Alexandra Cohen Foundation.
Flightpath Biosciences, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Flightpath Biosciences, Inc.'s valuation, stock price, and market status.